Adaptive Medias
OTCMKTS:ADTMAdaptive Medias, Inc. offers programmatic audience and content monetization. It provides these unique capabilities to monetize content efficiently across multiple marketing channels, including mobile, video and online display advertising. The company was founded by Omar Akram, Sal Aziz, and Qayed Murtaza Shareef on August 7, 2007 and is headquartered in Irvine, CA.
CMG Holdings Group
OTCMKTS:CMGOCMG Holdings Group, Inc., a marketing communications company, operates organizations in the alternative advertising, digital media, experiential and interactive marketing, and entertainment sectors in the United States. The company is involved in the production and promotion, event design, sponsorship evaluation, negotiation and activation, talent buying, show production, stage and set design, and data analysis and management activities. It also offers branding and design services, such as graphic, industrial and package designs across traditional and new media, public relations, social media, media development and relations, and interactive marketing platforms to provide its clients with customary private digital media networks for the design and development of individual broadcasting digital media channels, as well as to sell, promote, and enhance their digital media video content through mobile, online, and social mediums. In addition, the company provides develops, manages, and executes sales promotion programs. The company serves clients operating in the marketing communication industry. CMG Holdings Group, Inc. was founded in 2002 and is based in Chicago, Illinois.
Cogent Biosciences
NASDAQ:COGTCogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Mastermind
OTCMKTS:MMNDMastermind, Inc., an involvement marketing service agency, designs, creates, and develops branding and marketing campaigns for corporate clients. Its programs cover various forms, such as creating and managing digital content, designing campaign Websites/landing pages, social media and viral campaigns, mobile marketing initiatives, and brand communications. The company customers comprise of sports and entertainment, oil and gas, automotive, retail, restaurant, B2B, financial services, hotel and hospitality, consumer packaged goods, healthcare and pharmaceuticals, technology, and agricultural chemicals. Mastermind, Inc. was founded in 2012 and is based in Atlanta, Georgia. Mastermind, Inc. is a subsidiary of Mastermind Marketing, Inc.
Salon.com
OTCMKTS:SLNMSalon.com, LLC, an Internet media company, operates an online news Website in the United States. It produces a content Website with various subject-specific sections. The company's Salon.com Website features various voices and perspectives; and covers a range of topics, including news, politics, race, religion, culture, entertainment, sustainability, economy and innovation, technology, and business, as well as food, and health and science. Salon.com, LLC was founded in 1995 and is based in San Francisco, California. As of November 8, 2023, Salon.com, LLC operates as a subsidiary of Find.co.